Company Description

AMO Pharma is a privately held emerging biopharmaceutical company

The company intends to use the funds to advance two clinical-stage pipeline assets targeting rare muscular and central nervous system disorders and to expand the AMO Pharma pipeline through acquisition of additional development-stage products.